Elsa M. Hjerkinn - Concepedia

Author

Elsa M. Hjerkinn

Also Known As

E Hjerkinn, E M Hjerkinn, E. Hjerkinn, E. M. Hjerkinn, E.M. Hjerkinn, Elsa Hjerkinn, Elsa M Hjerkinn, Elsa M. HJERKINN, Elsa M. Hjerkinn, Hjerkinn E. M.

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Akershus University Hospital University of Michigan Glostrup Hospital

About

Elsa M. Hjerkinn is an author at Oslo University Hospital specializing in medicine, cardiovascular disease, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	498
2	Public Health	8	8	368
3	Health Sciences	4	4	190
4	Clinical Nutrition	1	1	18
5	Counseling	1	1	30

Elsa M. Hjerkinn

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events F Mindlen, Roberto Nordaby, M I Soto Ruiz, Queensland's institutional digital repository (The University of Queensland) Non-pharmacological InterventionPreventive MedicineCardiovascular DiseaseAntihypertensive TherapyClinical Trials	1996	154
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine Hilde Marie Angell Eid, Harald Arnesen, Elsa M. Hjerkinn, Metabolism ObesityMetabolic SyndromeMetabolic DisorderMedicinePhysiology	2004	140
Influence of long-term intervention with dietary counseling, long-chain n−3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia Elsa M. Hjerkinn, Ingebjørg Seljeflot, Ingrid Ellingsen, American Journal of Clinical Nutrition NutritionMetabolic SyndromeCardiovascular DiseaseHyperlipidemiaDyslipidemia	2005	112
A randomized clinical trial on<i>n</i>-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk Gunnar Einvik, Tor Ole Klemsdal, Leiv Sandvik, European Journal of Cardiovascular Prevention & Rehabilitation	2010	92
Effect of diet or very long chain -3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia Elsa M. Hjerkinn, Michael Abdelnoor, L. Breivik, European Journal of Cardiovascular Prevention & Rehabilitation	2006	91
Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome Marius Trøseid, Ingebjørg Seljeflot, Elsa M. Hjerkinn, Diabetes Care	2008	91
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men Ingrid Ellingsen, Elsa M. Hjerkinn, Ingebj rg Seljeflot, British Journal Of Nutrition Dietary AssessmentNutritionMetabolic SyndromeElderly MenNutritional Epidemiology	2007	78
Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men Marius Trøseid, Harald Arnesen, Elsa M. Hjerkinn, Metabolism ObesityMetabolic SyndromeNutritionOmega-3 Fatty AcidLipid Nutrition	2009	73
Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1 Paula Berstad, I. Seljeflot, Marit B. Veierød, Clinical Science	2003	61
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy Michael Hecht Olsen, Eigil Fossum, Aud Høieggen, Journal of Hypertension	2005	55

Page 1